September 18, 2025 - 00:27

Susan Monarez, the former head of the Centers for Disease Control and Prevention, recently testified before a Senate committee regarding her controversial dismissal by Health Secretary Robert F. Kennedy Jr. Monarez asserted that her termination was a direct result of her steadfast commitment to maintaining scientific integrity within the agency.
In her statements, she emphasized the importance of evidence-based decision-making in public health, arguing that Kennedy's approach poses a significant risk to the well-being of the public. Monarez expressed concerns over the potential consequences of undermining scientific principles in health policy, suggesting that such actions could lead to misguided strategies that endanger lives.
The Senate committee's hearing highlighted the ongoing tensions within the health department, as well as the broader implications of leadership decisions on public health initiatives. Monarez's testimony has sparked a renewed debate about the role of science in health governance and the responsibilities of public health officials to uphold rigorous standards.
March 23, 2026 - 04:17
Welcome to allergy season. Here's how to protect yourselfAs pollen counts surge, millions brace for the annual onslaught of seasonal allergies. The severity of symptoms, however, is not a universal experience. Experts emphasize that a combination of...
March 22, 2026 - 06:07
How crowd-control agents can affect healthA recent public demonstration has brought renewed scrutiny to the chemicals used for crowd control. The event, organized by a grieving mother and attended by dozens of supporters, highlighted...
March 21, 2026 - 19:59
Dueling Complaints Alleging Open Meeting Law Violations Emerge After…Two separate complaints alleging violations of the state`s Open Meeting Law have been filed following recent municipal proceedings, casting a spotlight on governmental transparency. The allegations...
March 21, 2026 - 07:34
Bipartisan bill aims to cut H-1B visa fees for health care workersA new bipartisan bill introduced in Congress aims to alleviate the severe shortage of doctors and medical researchers in the United States by reducing financial barriers for international talent....